IL138681A0 - Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b - Google Patents

Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b

Info

Publication number
IL138681A0
IL138681A0 IL13868199A IL13868199A IL138681A0 IL 138681 A0 IL138681 A0 IL 138681A0 IL 13868199 A IL13868199 A IL 13868199A IL 13868199 A IL13868199 A IL 13868199A IL 138681 A0 IL138681 A0 IL 138681A0
Authority
IL
Israel
Prior art keywords
attenuation
respiratory syncytial
virus
human respiratory
subgroup
Prior art date
Application number
IL13868199A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL138681A0 publication Critical patent/IL138681A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13868199A 1998-03-26 1999-03-22 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b IL138681A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7946698P 1998-03-26 1998-03-26
PCT/US1999/006225 WO1999049017A2 (en) 1998-03-26 1999-03-22 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b

Publications (1)

Publication Number Publication Date
IL138681A0 true IL138681A0 (en) 2001-10-31

Family

ID=22150746

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13868199A IL138681A0 (en) 1998-03-26 1999-03-22 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b

Country Status (9)

Country Link
EP (1) EP1064358A2 (xx)
JP (1) JP2002507408A (xx)
KR (1) KR20010080863A (xx)
CN (2) CN1600852A (xx)
AU (1) AU767193B2 (xx)
BR (1) BR9909076A (xx)
CA (1) CA2323927A1 (xx)
IL (1) IL138681A0 (xx)
WO (1) WO1999049017A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1298738C (zh) * 2000-06-23 2007-02-07 惠氏控股有限公司 修饰的麻疹病毒v蛋白
EP2110382A1 (en) * 2002-06-20 2009-10-21 Institut Pasteur Infectious cDNA of an improved vaccine strain of measles virus, use for immunogenic compositions
CA2520671C (en) 2003-03-28 2014-03-18 Medimmune Vaccines, Inc. Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
WO2008065752A1 (fr) * 2006-11-30 2008-06-05 National University Corporation Hokkaido University Agent immunothérapeutique contenant un arndi en tant que principe actif
EP2346990B1 (en) 2008-11-05 2016-01-06 Merck Sharp & Dohme Corp. Live, attentuated respiratory syncytial virus
EP2420242A1 (en) 2010-08-20 2012-02-22 Lauer, Ulrich M. Oncolytic measles virus
JP6453063B2 (ja) * 2014-12-02 2019-01-16 国立大学法人北海道大学 アジュバント組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3045581B2 (ja) * 1991-10-14 2000-05-29 社団法人北里研究所 麻疹ワクチンウイルス株同定方法
TW275632B (xx) * 1992-04-21 1996-05-11 American Cyanamid Co
EP0932684A2 (en) * 1996-09-27 1999-08-04 American Cyanamid Company 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales

Also Published As

Publication number Publication date
AU767193B2 (en) 2003-11-06
BR9909076A (pt) 2000-12-05
JP2002507408A (ja) 2002-03-12
EP1064358A2 (en) 2001-01-03
WO1999049017A2 (en) 1999-09-30
KR20010080863A (ko) 2001-08-25
CN1294628A (zh) 2001-05-09
AU3109599A (en) 1999-10-18
CN1600852A (zh) 2005-03-30
CN1177927C (zh) 2004-12-01
WO1999049017A3 (en) 1999-12-16
CA2323927A1 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
EG24026A (en) Respiratory syncytial virus replication inhibitors
IL147327A0 (en) Respiratory syncytial virus replication inhibitors
HK1045998B (zh) 呼吸道合胞病毒複製抑制劑
EP1112091A4 (en) FAST DEEP TEMPERATURE PRESSURE STERILIZATION AND VACCINE PRODUCTION
HK1042084B (zh) 取代的苯並咪唑及其製備和用途
AP2001002366A0 (en) Systems and methods for aerosolizing pharmacetical formulations
HUP0103267A2 (hu) Glifozát-tartalmú készítmények és alkalmazásuk
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
IL141562A0 (en) Particulate compositions for pulmonary delivery and methods for the preparation thereof
SG85237A1 (en) Breathable and liquid-impervious composite sheet
IL138609A0 (en) Antipicornaviral compounds, their preparation and use
HUP0102585A2 (hu) Tienil-azolilalkoxietánamin-származékok, ezek előállítása és gyógyszerkénti alkalmazásuk
EP0975363A4 (en) MITIGATED RESPIRATORY SYNCYTIAL VIRUS
IL138681A0 (en) Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
ATE276234T1 (de) Harnstoffderivate zur schmerzbekämpfung
AU2000277264A1 (en) Heat-moisture exchanger and nebulization device
AU6200399A (en) Avian pneumovirus vaccine and diagnostic agent
HUP0102409A3 (en) Pyrimidin-aminomethhyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
EP0917592A4 (en) REDUCED RSV
AU9654601A (en) Method and composition for the treatment of blackwater collection systems
HUP0203771A3 (en) Disinfectant agent concentrate and its use
EP1096889A4 (en) HOSE DEVICE FOR CLEAN BREATH
GB9927353D0 (en) Virus preparation and use
IL137076A0 (en) Bibapctitide-based pharmaceutical compositions for imaging and treating thrombi
HK1006915A2 (en) Vertebras orthopaedic net-support